Metabolic adverse events and comorbidity in chronic rheumatoid arthritis patients.
Recruiting
- Conditions
- rheumatoid artritiscardiovascular diseasesglucose intoleranceinsuline resistanceischemic heart diseaseheart failure
- Registration Number
- NL-OMON20413
- Lead Sponsor
- Top Institute Pharma
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
Chronic rheumatoid arthritis (according to ACR criteria for rheumatoid arthritis; disease duration over 2 years).
Exclusion Criteria
None
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Influence of disease-activity (by DAS and erosive joint damage) on metabolic parameters and comorbidities (insulin resistance, glucose intolerance, ischemic heart disease, heart failure, lipids).
- Secondary Outcome Measures
Name Time Method Effects of certain medication (glucocorticoids) on these parameters.